Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens?... by Bistline, Kathryn Lou

Subjects: “…HIV/TB co-infection…”
Get full text